NCT06951945View on ClinicalTrials.gov

Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With Obesity

PHASE1CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

July 18, 2024

Primary Completion Date

December 23, 2024

Study Completion Date

December 23, 2024

Conditions

Obesity

Interventions

DRUG

THDBH120 injection

Participants received THDBH120 by subcutaneous injection.

DRUG

Placebo of THDBH120 injection

Participants received placebo by subcutaneous injection.

Trial Locations (2)

Unknown

The First Affiliated Hospital of Bengbu Medical University, Anhui

Hangzhou First People's Hospital, Zhejiang

All Listed Sponsors

lead

Tonghua Dongbao Pharmaceutical Co.,Ltd

INDUSTRY

NCT06951945 - Multiple Dose Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Efficacy of THDBH120 in Chinese Patients With Obesity | Biotech Hunter | Biotech Hunter